10.0.3.19

Deal Roundup: HIG Capital agrees Celerion sale to THL Partners, GTCR closes Fiduciary acquisition

0
HIG Capital has agreed to sell clinical pharmacology and bioanalytical sciences specialist Celerion to THL Partners. Cel